SCHEMBL1023713

SCHEMBL1023713

OC(C(Cl)(Cl)Cl)C(Cl)(Cl)Cl

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.58
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6029543 0.76 LMNA (0.44) LMNA
SCHEMBL1187616 0.76 LMNA (0.44) LMNA
SCHEMBL7990072 0.76 LMNA (0.44) LMNACYP2C19
Chloral Hydrate SCHEMBL34327 0.74
Chloral Hydrate SCHEMBL6065223 0.74 LMNA (1.00) LMNACYP2C19
Chloral Hydrate SCHEMBL6729819 0.70
Chloral Hydrate SCHEMBL1697787 0.70
SCHEMBL873504 0.70
Chloral Hydrate SCHEMBL11407225 0.70
Chloral Hydrate SCHEMBL5606401 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106858134-A A kind of feed addictive containing separate sources lipase and its application in yellow-feather broiler fodder 吴广兵 2017-06-20 CN claimed
CN-106631709-A Hydroxytyrosol extraction and nitration method 中国林业科学研究院林产化学工业研究所 2017-05-10 CN claimed
CN-102372721-A Preparation method for magnolin SUZHOU BAOZETANG MEDICAL TECH 2012-03-14 CN claimed
US-4334052-A Rigid, non-cellular polyurethane modified with reaction product of an isocyanate and an alcohol BASF WYANDOTTE CORPORATION (US) 1982-06-08 US claimed
US-4334032-A Foamed polymers containing low molecular weight urethane modifier compound BASF WYANDOTTE CORPORATION (US) 1982-06-08 US claimed
US-12577373-B2 Carbodiimide composition, curing agent composition, coating composition and resin cured product ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-03-17 US disclosed
EP-4446310-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND Asahi Kasei Kabushiki Kaisha (JP) 2024-10-16 EP disclosed
WO-2024063100-A1 METHOD FOR PRODUCING POLYVALENT CARBODIIMIDE B 旭化成株式会社 2024-03-28 WO disclosed
WO-2023106377-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND 旭化成株式会社 2023-06-15 WO disclosed
US-20230135772-A1 CARBODIIMIDE COMPOSITION, CURING AGENT COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-05-04 US disclosed
EP-4130154-A1 CARBODIIMIDE COMPOSITION, HARDENER COMPOSITION, COATING COMPOSITION, AND CURED RESIN OBJECT Asahi Kasei Kabushiki Kaisha (JP) 2023-02-08 EP disclosed
US-11186601-B2 Metallocene compounds having appended Lewis acids and polymerization therewith EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-11-30 US disclosed
US-4334052-A Rigid, non-cellular polyurethane modified with reaction product of an isocyanate and an alcohol BASF WYANDOTTE CORPORATION (US) 1982-06-08 US disclosed
US-4334032-A Foamed polymers containing low molecular weight urethane modifier compound BASF WYANDOTTE CORPORATION (US) 1982-06-08 US disclosed
US-4331593-A TRIPEPTIDE SMITHWICK JR EDWARD L 1982-05-25 US disclosed
US-4326043-A FIREPROOFING BASF WYANDOTTE CORPORATION (US) 1982-04-20 US disclosed
EP-0001684-B1 TETRAPEPTIDES, METHODS FOR THEIR PREPARATION AND THEIR USE IN ANALGESIC COMPOSITIONS ELI LILLY AND COMPANY (US) 1981-09-02 EP disclosed
US-4264491-A OLIGOPEPTIDE ELI LILLY AND COMPANY (US) 1981-04-28 US disclosed
US-4189476-A Combating pests with O,S-dialkyl-O-haloalkyl-phosphorothiolates Nihon Takushu Noyaku Seizo K.K. (JP) 1980-02-19 US disclosed
EP-0000528-A1 Organophosphonic ester compounds, process for their preparation and their utilisation as insecticides, acaricides and nematocides NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1979-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577373-B2 Carbodiimide composition, curing agent composition, coating composition and resin cured product CD38, PARP9, MCCC2 LMNA 1936/4885CYP2C19 994/4885
US-11186601-B2 Metallocene compounds having appended Lewis acids and polymerization therewith PF4, C5, ORC3 LMNA 1124/4885CYP2C19 1718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.